Ketoreductase polypeptides for the preparation of phenylephrine
The disclosure relates to engineered ketoreductase polypeptides and processes of using the polypeptides for production of phenylephrine.
1. An engineered polynucleotide encoding an engineered polypeptide capable of converting 1-(3-hydroxyphenyl)-2-(methylamino)ethanone to (R)-phenylephrine, wherein the amino acid sequence of the engineered polypeptide has at least 95% identity to SEQ ID NO: 4 and comprises the residue difference C190G and at least one further residue difference at a position of SEQ ID NO: 4 selected from a position corresponding to position 2, 11, 64, 76, 95, 99, 148, 152, 153, 159, 197, 200, 202, 206, and 249.
2. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the at least one further residue difference comprises A202F.
3. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the at least one further residue difference comprises M206C.
4. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the at least one further residue difference comprises V95M.
5. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the amino acid sequence further comprises at least two residue differences selected from V95M, S96L, L147I, A202F, M206C, and Y202F.
6. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the amino acid sequence further comprises the residue differences V95M, A202F, and M206C.
7. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the amino acid sequence comprises the residue differences V95M, C190G, A202F, M206C, and Y249F.
8. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the amino acid sequence comprises the combination of residue differences of any one of SEQ ID NO: 4, 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, or 34 as compared to SEQ ID NO: 2.
9. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the amino acid sequence further comprises at least one residue difference selected from T2S, I11L, A64V, T76I, V95M, S96L,V99L, V148L, T152A, L153M, S159T, D197A, and E200P.
10. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the engineered polypeptide is capable of stereospecifically converting 1-(3-hydroxyphenyl)-2-(methylamino)ethanone to (R)-phenylephrine in a enantiomeric excess of at least 99%.
11. The engineered polynucleotide encoding the engineered polypeptide of claim 1 , wherein the engineered polypeptide comprises a sequence selected from the group consisting of SEQ ID NO: 6, 8, 10, 12, 14, 16, 18, 20, 22, 24, 26, 28, 30, 32, and 34.
12. The engineered polynucleotide of claim 1 , wherein the polynucleotide comprises a sequence selected from the group consisting of SEQ ID NO: 5, 7, 9, 11, 13, 15, 17, 19, 21, 23, 25, 27, 29, 31, and 33.
13. An expression vector comprising the engineered polynucleotide of claim 1 .
14. The vector of claim 13 , further comprising at least one control sequence.
15. A host cell comprising the engineered polynucleotide of claim 1 .
16. A host cell comprising the expression vector of claim 13 .
17. A method of preparing an engineered polypeptide, comprising culturing the host cell of claim 13 , under conditions suitable for expression of the engineered polypeptide, optionally further comprising isolating the engineered polypeptide.